Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 2, 1998, Pages 161-169

  Gosden, P E ^a   Andrews, J M ^b   Bowker, K E ^a   Holt, H A ^a   MacGowan, A P ^a   Reeves, D S ^a   Sunderland, J ^a   Wise, R ^b  

^a NORTH BRISTOL NHS TRUST   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; GENTAMICIN; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTERIACEAE; ENTEROCOCCUS; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 0031855044     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.2.161     Document Type: Article

References (17)

1. Andrews, J. M., Brown, D. & Wise, R. (1996). A survey of antimicrobial sensitivity testing in the United Kingdom. Journal of Antimicrobial Chemotherapy 37, 187-8.
2. Working Party of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 1-50.
3. National Committee for Clinical Laboratory Standards. (1994). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition: M7-A3. NCCLS, Villanova, PA.
4. National Committee for Clinical Laboratory Standards. (1994). Performance Standards for Antimicrobial Disk Susceptibility Tests - Fifth Edition: M2-A5. NCCLS, Villanova, PA.
5. Wise, R., Amyes, S. G. B., Andrews, J. M., Bridson, E., Brown, D. F. J., Felmingham, D. et al. (1996). Supplementary report by the Working Party on antibiotic sensitivity testing of the British Society for Antimicrobial Chemotherapy. (1996). Journal of Antimicrobial Chemotherapy 38, 1103-5.
6. King, A., Phillips, I., Amyes, S., Lewin, C., Paton, R. & Tillotson, G. (1993). MIC audit for routine ciprofloxacin sensitivity testing. Journal of Antimicrobial Chemotherapy 31, 321-3.
7. Chen, H. Y., Yuan, M., Ibrahim-Elmagboul, I. B. & Livermore, D. M. (1995). National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 35, 521-34.
8. Livermore, D. M. (1997). Sensitivity testing of ciprofloxacin for Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 39, 309-17.
9. Cavenaghi, L. A., Biganzoli, E., Danese, A. & Parenti, F. (1992). Diffusion of teicoplanin and vancomycin in agar. Diagnostic Microbiology and Infectious Diseases 15, 253-8.
10. Woodford, N., Johnson, A. P. & George, R. C. (1991). Detection of glycopeptide resistance in clinical isolates of Gram-positive bacteria. Journal of Antimicrobial Chemotherapy 28, 483-6.
11. Woodford, N., Johnson, A. P., Morrison, D. & Speller, D. C. E. (1995). Current perspectives on glycopeptide resistance. Clinical Microbiology Reviews 8, 585-615.
12. Snell, J. J. S., Brown, D. F. J., Perry, S. F. & George, R. (1993). Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology. Journal of Antimicrobial Chemotherapy 32, 401-11.
13. Chomarat, M., Espinouse, D. & Flandrois, J. P. (1991). Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity. Journal of Antimicrobial Chemotherapy 27, 475-80.
14. Felmingham, D., Solomonides, K., O'Hare, M. D., Wilson, A. P. R. & Grüneberg, R. N. (1987). The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci. Journal of Antimicrobial Chemotherapy 20, 609-10.
15. Jansen, B., Stefanik, D., Hungenberg, I. & Schunacher-Perdreau, F. (1993). Evaluation of three methods (agar dilution, Etest, agar disc diffusion) for susceptibility testing of staphylococci and enterococci against vancomycin and teicoplanin. In Program and Abstracts of the Sixth European Congress of Clinical Microbiology and Infectious Diseases. Abstract 1019, p. 240. European Society of Clinical Microbiology and Infectious Disease.
16. Jean-Pierre, H., Rivière, M., Darbas, H. & Boyer, G. (1993). In-vitro activity of glycopeptides on 114 coagulase-negative staphylococci: problems with the teicoplanin diffusion test, 'alert' parameters indicating need for MIC determination. Pathologie Biologie 41, 531-6.
17. Acar, J. F. & Goldstein, F. W. (1996). Disk susceptibility test. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 1-52. Williams & Wilkins, Baltimore, MD.